<h4>Purpose</h4>To evaluate the correlation between HER2 expression levels measured by HER2 mRNA using Oncotype DX and by immunohistochemistry (IHC) in hormone receptor-positive (HR+) and HER2-negative (HER2-) early breast cancer. The gene discussed is ERBB2; the disease is breast carcinoma.